DJ-1 isoforms in whole blood as potential biomarkers of Parkinson disease
10.1038/srep00954
Crossref journal-article
Springer Science and Business Media LLC
Scientific Reports (297)
Bibliography

Lin, X., Cook, T. J., Zabetian, C. P., Leverenz, J. B., Peskind, E. R., Hu, S.-C., Cain, K. C., Pan, C., Edgar, J. S., Goodlett, D. R., Racette, B. A., Checkoway, H., Montine, T. J., Shi, M., & Zhang, J. (2012). DJ-1 isoforms in whole blood as potential biomarkers of Parkinson disease. Scientific Reports, 2(1).

Authors 15
  1. Xiangmin Lin (first)
  2. Travis J. Cook (additional)
  3. Cyrus P. Zabetian (additional)
  4. James B. Leverenz (additional)
  5. Elaine R. Peskind (additional)
  6. Shu-Ching Hu (additional)
  7. Kevin C. Cain (additional)
  8. Catherine Pan (additional)
  9. John Scott Edgar (additional)
  10. David R. Goodlett (additional)
  11. Brad A. Racette (additional)
  12. Harvey Checkoway (additional)
  13. Thomas J. Montine (additional)
  14. Min Shi (additional)
  15. Jing Zhang (additional)
References 42 Referenced 92
  1. Lang, A. E. & Lozano, A. M. Parkinson's disease. Second of two parts. N Engl J Med 339, 1130–1143 (1998). (10.1056/NEJM199810153391607) / N Engl J Med by AE Lang (1998)
  2. Wright Willis, A., Evanoff, B. A., Lian, M., Criswell, S. R. & Racette, B. A. Geographic and ethnic variation in Parkinson disease: a population-based study of US Medicare beneficiaries. Neuroepidemiology 34, 143–151 (2010). (10.1159/000275491) / Neuroepidemiology by A Wright Willis (2010)
  3. Jankovic, J. Parkinson's disease: clinical features and diagnosis. J Neurol Neurosurg Psychiatry 79, 368–376 (2008). (10.1136/jnnp.2007.131045) / J Neurol Neurosurg Psychiatry by J Jankovic (2008)
  4. Tolosa, E., Wenning, G. & Poewe, W. The diagnosis of Parkinson's disease. Lancet Neurol 5, 75–86 (2006). (10.1016/S1474-4422(05)70285-4) / Lancet Neurol by E Tolosa (2006)
  5. Hong, Z. et al. DJ-1 and alpha-synuclein in human cerebrospinal fluid as biomarkers of Parkinson's disease. Brain 133, 713–726 (2010). (10.1093/brain/awq008) / Brain by Z Hong (2010)
  6. Bonifati, V. et al. DJ-1( PARK7), a novel gene for autosomal recessive, early onset parkinsonism. Neurol Sci 24, 159–160 (2003). (10.1007/s10072-003-0108-0) / Neurol Sci by V Bonifati (2003)
  7. Taira, T. et al. DJ-1 has a role in antioxidative stress to prevent cell death. EMBO Rep 5, 213–218 (2004). (10.1038/sj.embor.7400074) / EMBO Rep by T Taira (2004)
  8. Diamandis, E. P., Yousef, G. M., Petraki, C. & Soosaipillai, A. R. Human kallikrein 6 as a biomarker of Alzheimer's disease. Clin Biochem 33, 663–667 (2000). (10.1016/S0009-9120(00)00185-5) / Clin Biochem by EP Diamandis (2000)
  9. Bogdanov, M. et al. Metabolomic profiling to develop blood biomarkers for Parkinson's disease. Brain 131, 389–396 (2008). (10.1093/brain/awm304) / Brain by M Bogdanov (2008)
  10. Shehadeh, L. A. et al. SRRM2, a potential blood biomarker revealing high alternative splicing in Parkinson's disease. PLoS One 5, e9104 (2010). (10.1371/journal.pone.0009104) / PLoS One by LA Shehadeh (2010)
  11. Stern, E. et al. Label-free biomarker detection from whole blood. Nat Nanotechnol 5, 138–142 (2010). (10.1038/nnano.2009.353) / Nat Nanotechnol by E Stern (2010)
  12. Shi, M. et al. Significance and confounders of peripheral DJ-1 and alpha-synuclein in Parkinson's disease. Neurosci Lett 480, 78–82 (2010). (10.1016/j.neulet.2010.06.009) / Neurosci Lett by M Shi (2010)
  13. McKhann, G. et al. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 34, 939–944 (1984). (10.1212/WNL.34.7.939) / Neurology by G McKhann (1984)
  14. Gibb, W. R. & Lees, A. J. The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease. J Neurol Neurosurg Psychiatry 51, 745–752 (1988). (10.1136/jnnp.51.6.745) / J Neurol Neurosurg Psychiatry by WR Gibb (1988)
  15. Montine, K. S. et al. Distribution of reducible 4-hydroxynonenal adduct immunoreactivity in Alzheimer disease is associated with APOE genotype. J Neuropathol Exp Neurol 57, 415–425 (1998). (10.1097/00005072-199805000-00005) / J Neuropathol Exp Neurol by KS Montine (1998)
  16. Kawashima, Y. et al. High-yield peptide-extraction method for the discovery of subnanomolar biomarkers from small serum samples. J Proteome Res 9, 1694–1705 (2010). (10.1021/pr9008018) / J Proteome Res by Y Kawashima (2010)
  17. Shi, M. et al. Mortalin: a protein associated with progression of Parkinson disease? J Neuropathol Exp Neurol 67, 117–124 (2008). (10.1097/nen.0b013e318163354a) / J Neuropathol Exp Neurol by M Shi (2008)
  18. Jin, J. et al. Quantitative proteomic analysis of mitochondrial proteins: relevance to Lewy body formation and Parkinson's disease. Brain Res Mol Brain Res 134, 119–138 (2005). (10.1016/j.molbrainres.2004.10.003) / Brain Res Mol Brain Res by J Jin (2005)
  19. Devic, I. et al. Salivary alpha-synuclein and DJ-1: potential biomarkers for Parkinson's disease. Brain 134, e178 (2011). (10.1093/brain/awr015) / Brain by I Devic (2011)
  20. Gygi, S. P., Corthals, G. L., Zhang, Y., Rochon, Y. & Aebersold, R. Evaluation of two-dimensional gel electrophoresis-based proteome analysis technology. Proc Natl Acad Sci USA 97, 9390–9395 (2000). (10.1073/pnas.160270797) / Proc Natl Acad Sci USA by SP Gygi (2000)
  21. Waragai, M. et al. α-Synuclein and DJ-1 as Potential Biological Fluid Biomarkers for Parkinson's Disease. Int J Mol Sci 11, 4257–4266 (2010). (10.3390/ijms11114257) / Int J Mol Sci by M Waragai (2010)
  22. Waragai, M. et al. Plasma levels of DJ-1 as a possible marker for progression of sporadic Parkinson's disease. Neurosci Lett 425, 18–22 (2007). (10.1016/j.neulet.2007.08.010) / Neurosci Lett by M Waragai (2007)
  23. Maita, C. et al. Secretion of DJ-1 into the serum of patients with Parkinson's disease. Neurosci Lett 431, 86–89 (2008). (10.1016/j.neulet.2007.11.027) / Neurosci Lett by C Maita (2008)
  24. Wang, J., Hoekstra, J. G., Zuo, C., Cook, T. J. & Zhang, J. Biomarkers of Parkinson's disease: current status and future perspectives. Drug Discovery Today (2012), in press: http://dx.doi.org/10.1016/j.drudis.2012.09.001 (10.1016/j.drudis.2012.09.001)
  25. Rush, J. et al. Immunoaffinity profiling of tyrosine phosphorylation in cancer cells. Nat Biotechnol 23, 94–101 (2005). (10.1038/nbt1046) / Nat Biotechnol by J Rush (2005)
  26. Choi, J. et al. Oxidative damage of DJ-1 is linked to sporadic Parkinson and Alzheimer diseases. J Biol Chem 281, 10816–10824 (2006). (10.1074/jbc.M509079200) / J Biol Chem by J Choi (2006)
  27. Saito, Y. et al. Preparation and application of monoclonal antibodies against oxidized DJ-1. Significant elevation of oxidized DJ-1 in erythrocytes of early-stage Parkinson disease patients. Neurosci Lett 465, 1–5 (2009). (10.1016/j.neulet.2009.08.074) / Neurosci Lett by Y Saito (2009)
  28. Kinumi, T., Kimata, J., Taira, T., Ariga, H. & Niki, E. Cysteine-106 of DJ-1 is the most sensitive cysteine residue to hydrogen peroxide-mediated oxidation in vivo in human umbilical vein endothelial cells. Biochem Biophys Res Commun 317, 722–728 (2004). (10.1016/j.bbrc.2004.03.110) / Biochem Biophys Res Commun by T Kinumi (2004)
  29. Canet-Avilés, R. M. et al. The Parkinson's disease protein DJ-1 is neuroprotective due to cysteine-sulfinic acid-driven mitochondrial localization. Proc Natl Acad Sci USA 101, 9103–9108 (2004). (10.1073/pnas.0402959101) / Proc Natl Acad Sci USA by RM Canet-Avilés (2004)
  30. Hao, L. Y., Giasson, B. I. & Bonini, N. M. DJ-1 is critical for mitochondrial function and rescues PINK1 loss of function. Proc Natl Acad Sci USA 107, 9747–9752 (2010). (10.1073/pnas.0911175107) / Proc Natl Acad Sci USA by LY Hao (2010)
  31. Tsuboi, Y. et al. DJ-1, a causative gene product of a familial form of Parkinson's disease, is secreted through microdomains. FEBS Lett 582, 2643–2649 (2008). (10.1016/j.febslet.2008.06.043) / FEBS Lett by Y Tsuboi (2008)
  32. Akazawa, Y. O. et al. Elevation of oxidized DJ-1 in the brain and erythrocytes of Parkinson disease model animals. Neurosci Lett 483, 201–205 (2010). (10.1016/j.neulet.2010.08.007) / Neurosci Lett by YO Akazawa (2010)
  33. Yoritaka, A. et al. Immunohistochemical detection of 4-hydroxynonenal protein adducts in Parkinson disease. Proc Natl Acad Sci USA 93, 2696–2701 (1996). (10.1073/pnas.93.7.2696) / Proc Natl Acad Sci USA by A Yoritaka (1996)
  34. Selley, M. L. (E)-4-hydroxy-2-nonenal may be involved in the pathogenesis of Parkinson's disease. Free Radic Biol Med 25, 169–174 (1998). (10.1016/S0891-5849(98)00021-5) / Free Radic Biol Med by ML Selley (1998)
  35. Ishimura, A. et al. Comparative study of hydrogen peroxide- and 4-hydroxy-2-nonenal-induced cell death in HT22 cells. Neurochem Int 52, 776–785 (2008). (10.1016/j.neuint.2007.09.008) / Neurochem Int by A Ishimura (2008)
  36. Natale, M. et al. A meta-analysis of two-dimensional electrophoresis pattern of the Parkinson's disease-related protein DJ-1. Bioinformatics 26, 946–952 (2010). (10.1093/bioinformatics/btq073) / Bioinformatics by M Natale (2010)
  37. Baglo, Y. et al. Photodynamic therapy with hexyl aminolevulinate induces carbonylation, posttranslational modifications and changed expression of proteins in cell survival and cell death pathways. Photochem Photobiol Sci 10, 1137–1145 (2011). (10.1039/c0pp00369g) / Photochem Photobiol Sci by Y Baglo (2011)
  38. Duan, X., Kelsen, S. G. & Merali, S. Proteomic analysis of oxidative stress-responsive proteins in human pneumocytes: insight into the regulation of DJ-1 expression. J Proteome Res 7, 4955–4961 (2008). (10.1021/pr800295j) / J Proteome Res by X Duan (2008)
  39. Ferrington, D. A. & Kapphahn, R. J. Catalytic site-specific inhibition of the 20S proteasome by 4-hydroxynonenal. FEBS Lett 578, 217–223 (2004). (10.1016/j.febslet.2004.11.003) / FEBS Lett by DA Ferrington (2004)
  40. Garcia, A. et al. Differential proteome analysis of TRAP-activated platelets: involvement of DOK-2 and phosphorylation of RGS proteins. Blood 103, 2088–2095 (2004). (10.1182/blood-2003-07-2392) / Blood by A Garcia (2004)
  41. Ethen, C. M., Reilly, C., Feng, X., Olsen, T. W. & Ferrington, D. A. Age-related macular degeneration and retinal protein modification by 4-hydroxy-2-nonenal. Invest Ophthalmol Vis Sci 48, 3469–3479 (2007). (10.1167/iovs.06-1058) / Invest Ophthalmol Vis Sci by CM Ethen (2007)
  42. Alberio, T. et al. Changes in the two-dimensional electrophoresis pattern of the Parkinson's disease related protein DJ-1 in human SH-SY5Y neuroblastoma cells after dopamine treatment. IUBMB Life 62, 688–692 (2010). (10.1002/iub.371) / IUBMB Life by T Alberio (2010)
Dates
Type When
Created 12 years, 8 months ago (Dec. 11, 2012, 5:08 a.m.)
Deposited 2 years, 7 months ago (Jan. 5, 2023, 11:18 p.m.)
Indexed 3 weeks, 2 days ago (Aug. 6, 2025, 8:53 a.m.)
Issued 12 years, 8 months ago (Dec. 11, 2012)
Published 12 years, 8 months ago (Dec. 11, 2012)
Published Online 12 years, 8 months ago (Dec. 11, 2012)
Funders 0

None

@article{Lin_2012, title={DJ-1 isoforms in whole blood as potential biomarkers of Parkinson disease}, volume={2}, ISSN={2045-2322}, url={http://dx.doi.org/10.1038/srep00954}, DOI={10.1038/srep00954}, number={1}, journal={Scientific Reports}, publisher={Springer Science and Business Media LLC}, author={Lin, Xiangmin and Cook, Travis J. and Zabetian, Cyrus P. and Leverenz, James B. and Peskind, Elaine R. and Hu, Shu-Ching and Cain, Kevin C. and Pan, Catherine and Edgar, John Scott and Goodlett, David R. and Racette, Brad A. and Checkoway, Harvey and Montine, Thomas J. and Shi, Min and Zhang, Jing}, year={2012}, month=dec }